Literature DB >> 15341929

A method for separating ALA from ALA derivatives using ionic exchange extraction.

Gabriela Di Venosa1, Haydée Fukuda, Christian Perotti, Alcira Batlle, Adriana Casas.   

Abstract

Photodynamic therapy using 5-aminolevulinic acid (ALA)-induced protoporphyrin IX is a recent approach to detect and treat some malignancies. The use of lipophilic derivatives of ALA has been exploited in the last years to enhance ALA penetration. In this paper, we describe the application of the Mauzerall and Granick's method [J. Biol. Chem. 219 (1956) 435] to the quantification of ALA derivatives. We also describe the employment of reusable ion-exchange chromatographic columns for separating mixtures of ALA and ALA derivatives present in biological samples. The relation between 555 nm absorbance and ALA or ALA derivative concentration was linear up to 100 nmol/ml and the limit of detection of ALA and ALA derivatives was 1 nmol per ml. We employed a Dowex 50 X8 hydrogen form resin to separate ALA from the derivatives. Whereas 90+/-4% of the total ALA was eluted using sodium acetate, only 3-9% of the ALA derivatives was recovered. Only upon exposure of the resin to a high HCl concentration, the ALA derivatives were completely released. We employed this new method for the separation of ALA from ALA derivatives in cells exposed to different ALA compounds.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15341929     DOI: 10.1016/j.jphotobiol.2004.07.001

Source DB:  PubMed          Journal:  J Photochem Photobiol B        ISSN: 1011-1344            Impact factor:   6.252


  2 in total

1.  Mechanisms of 5-aminolevulinic acid ester uptake in mammalian cells.

Authors:  Lorena Rodriguez; Alcira Batlle; Gabriela Di Venosa; Sinan Battah; Paul Dobbin; Alexander J Macrobert; Adriana Casas
Journal:  Br J Pharmacol       Date:  2006-04       Impact factor: 8.739

2.  Porphyrin synthesis from ALA derivatives for photodynamic therapy. In vitro and in vivo studies.

Authors:  C Perotti; H Fukuda; G DiVenosa; A J MacRobert; A Batlle; A Casas
Journal:  Br J Cancer       Date:  2004-04-19       Impact factor: 7.640

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.